ELEVANCE HEALTH INC (ELV) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:ELV - US0367521038 - Common Stock
ELV Key Statistics, Chart & Performance
The current stock price of ELV is 333.49 USD. In the past month the price increased by 4.84%. In the past year, price decreased by -12.73%.
ELV Latest News, Press Relases and Analysis
ELV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 15.87 | 302.09B | ||
| HUM | HUMANA INC | 13.37 | 30.43B | ||
| CNC | CENTENE CORP | 9.62 | 19.10B | ||
| HQY | HEALTHEQUITY INC | 25.51 | 8.24B | ||
| MOH | MOLINA HEALTHCARE INC | 8.16 | 7.74B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 3.88B | ||
| PGNY | PROGYNY INC | 38.33 | 2.08B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.37B |
Related stock screener links
About ELV
Company Profile
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 103,158 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Company Info
ELEVANCE HEALTH INC
220 Virginia Avenue
Indianapolis INDIANA US
Employees: 103158
Phone: 18003311476
ELEVANCE HEALTH INC / ELV FAQ
Can you describe the business of ELEVANCE HEALTH INC?
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 103,158 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
What is the current price of ELV stock?
The current stock price of ELV is 333.49 USD. The price increased by 0.83% in the last trading session.
Does ELV stock pay dividends?
ELEVANCE HEALTH INC (ELV) has a dividend yield of 2.02%. The yearly dividend amount is currently 6.55.
How is the ChartMill rating for ELEVANCE HEALTH INC?
ELV has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Would investing in ELEVANCE HEALTH INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ELV.
Is ELEVANCE HEALTH INC (ELV) expected to grow?
The Revenue of ELEVANCE HEALTH INC (ELV) is expected to grow by 13.06% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the upcoming earnings date for ELEVANCE HEALTH INC?
ELEVANCE HEALTH INC (ELV) will report earnings on 2026-01-21, after the market close.
ELV Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ELV. When comparing the yearly performance of all stocks, ELV is a bad performer in the overall market: 65.3% of all stocks are doing better.
ELV Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ELV. There are concerns on the financial health of ELV while its profitability can be described as average.
ELV Financial Highlights
Over the last trailing twelve months ELV reported a non-GAAP Earnings per Share(EPS) of 30.68. The EPS decreased by -11.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.84% | ||
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| Debt/Equity | 0.71 |
ELV Forecast & Estimates
29 analysts have analysed ELV and the average price target is 391.07 USD. This implies a price increase of 17.27% is expected in the next year compared to the current price of 333.49.
For the next year, analysts expect an EPS growth of -8.18% and a revenue growth 13.06% for ELV